A detailed history of Sofinnova Investments, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 406,645 shares of GH stock, worth $12.5 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
406,645
Holding current value
$12.5 Million
% of portfolio
0.88%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.3 - $36.29 $9.07 Million - $14.8 Million
406,645 New
406,645 $9.32 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $6.92 Million - $18.6 Million
-239,995 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $358,594 - $746,841
7,432 Added 3.2%
239,995 $15.9 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $17.1 Million - $23.2 Million
192,563 Added 481.41%
232,563 $23.3 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $3.95 Million - $5.29 Million
40,000 New
40,000 $5 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.14B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.